Price achieved for first indication vs. ASMR
CRA Life Sciences continues its series on leveraging RADAR, its orphan drug data repository, with a focus on PMA trends between ASMR outcomes and average annual treatment costs. The analysis shows a clear correlation between the ASMR rating and the level of price achieved.
Costello Medical Consulting gains B Corp Certification
Leading the way in reinventing business by pursuing purpose as well as profit.
Axol Bioscience acquires Phenocell to advance human disease models
Acquisition expands Axol’s iPSC-derived cell models and service offering to include ophthalmology and dermatologyCAMBRIDGE / EDINBURGH, UK, and GRASSE, FRANCE, 21 October 2024: Axol Bioscience Ltd.
eg technology launch Technology Readiness Level (TRL) assessment
Comprised of both a self-assessment diagnostic tool, through which innovators can assess the Technology Readiness Level of each integral element of their development
Key challenges in the medical device startup landscape
Co-authored by Samantha Shelley, SQMS.
New lab to open to make cutting-edge CAR-T cells in Cambridge
A new state-of-the-art laboratory is set to open at Addenbrooke’s Hospital that will deliver ‘home-grown’ CAR-T cells to help improve treatment for blood cancers.
The rise of the next-Ggn CDMO: strategies for reducing risk and time to market
Creating and producing advanced drug-device combinations, like autoinjectors and pen injectors, requires a depth and breadth of technical expertise.
Costello Medical Consulting Annual Impact Report
Our 2023/24 Annual Impact Report is available to read.
Human skin map gives 'recipe' to build skin and could help prevent scarring
For the first time, researchers have created a single cell atlas of prenatal human skin to understand how skin forms, and what goes wrong in disease.
Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base
Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing
Companies to develop integration strategies for Fresenius Kabi’s portfolio of Cell Therapy Technologies within Cellular Origins’ Constellation automation platform Initial research to focus on integration of the Cue® Cell Processing System for automated smaNuclera closes $75 million USD financing
Series C round led by Elevage Medical Technologies. Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally.
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug developmentBaltimore, MD – Sapio Sciences, the science-aware™
Shift Bioscience raises $16M to advance cell simulation AI platform
Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for identification of safe rejuvenation genes, a fundamental step forward in theMenopause matters – how to support staff going through menopause
Menopause will affect almost half the workforce in the UK. But this natural stage of life is still taboo for lots of employers. This Menopause Awareness Month, we’re looking at how to create a supportive environment for menopausal employees.
Guardtech Group bag third win in two months with West Suffolk Innovation of the Year Award
Haverhill-based cleanroom construction specialists scoop Bury Free Press Awards win for Innovation with portable container business Cleancube Mobile Cleanrooms
Antiverse raises £3.5M ($4.6M) to advance generative AI antibody design platform
Increases total equity financing raised to £7.2M ($10.1M) New facilities in Boston and Prague will provide increased capacity to deliver pipeline of pharma and biotech projects Funding to progress internal assets targeting multiple GPCRs and Ion
Leadership change at CMR Surgical
CMR Surgical, the global surgical robotics business, announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.
Benefits of a Nitrosamine Selective Detector
Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug manufacturing process and storage under certain conditions.
Ensuring cosmetic safety: the vital role of ATNC analysis
Cosmetics aren't just about enhancing beauty; they're about trust and safety. In the intricate dance of beauty and science, the discovery of nitrosamines within our cherished products has cast a shadow, highlighting the need for safety measures.
Alleo and Ubiquigent enter AI-driven strategic partnership to accelerate DUB-focused drug discovery
Collaboration will combine Alleo’s AI-based platform with Ubiquigent’s expertise in the DUB space to advance DUB-focused preclinical programmes
Digital marketing for B2B in China: what you need to know and how to do it
China is rapidly evolving into the world’s most digitised economy, making digital marketing essential for any company aiming to succeed there.
Helping rediscover purpose and fulfilment after retirement: Barry’s story
After a long career in engineering, Barry decided to retire when the company closed his office. But adjusting to life outside of work was a struggle – he found it difficult to fill his days and he lost the sense of purpose his job had given him. With the right guidance and support, Barry discovered a new passion that’s now helping him to grow his skills and find fulfilment in the next stage of…
Research sets global standard for Crohn’s treatment
Trial results published by Cambridge researchers earlier this year and involving patients at Addenbrooke’s Hospital are helping to set new global standards for the treatment of Crohn’s disease, it has emerged.
Qkine wins ‘Scale-up of the Year’ at the 2024 Cambridge Independent Business Awards
On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the Cambridge Independent Business awards ceremony held in the spectacular Great Hall at King’s College, Cambridge.